United States Huntington's Disease Therapeutics Market Report 2016

Publisher Name :
Date: 28-Oct-2016
No. of pages: 119
Inquire Before Buying

Notes:

Sales, means the sales volume of Huntington's Disease Therapeutics

Revenue, means the sales value of Huntington's Disease Therapeutics

This report studies sales (consumption) of Huntington's Disease Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Auspex Pharmaceuticals

- Alnylam Pharmaceuticals

- Intellect Neurosciences Incorporation

- Lundbeck A/S

- Prana Biotechnology Limited

- Raptor Pharmaceuticals

- Sangamo Biosciences

- Teva Pharmaceutical Industries

- Trophos SA

- Valeant Pharmaceuticals International

- Vertex Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Huntington's Disease Therapeutics in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Huntington's Disease Therapeutics Market Report 2016

Table of Contents
United States Huntington's Disease Therapeutics Market Report 2016
1 Huntington's Disease Therapeutics Overview
1.1 Product Overview and Scope of Huntington's Disease Therapeutics
1.2 Classification of Huntington's Disease Therapeutics
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Huntington's Disease Therapeutics
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Huntington's Disease Therapeutics (2011-2021)
1.4.1 United States Huntington's Disease Therapeutics Sales and Growth Rate (2011-2021)
1.4.2 United States Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
2 United States Huntington's Disease Therapeutics Competition by Manufacturers
2.1 United States Huntington's Disease Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Huntington's Disease Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Huntington's Disease Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Huntington's Disease Therapeutics Market Competitive Situation and Trends
2.4.1 Huntington's Disease Therapeutics Market Concentration Rate
2.4.2 Huntington's Disease Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Huntington's Disease Therapeutics Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Huntington's Disease Therapeutics Sales and Market Share by Type (2011-2016)
3.2 United States Huntington's Disease Therapeutics Revenue and Market Share by Type (2011-2016)
3.3 United States Huntington's Disease Therapeutics Price by Type (2011-2016)
3.4 United States Huntington's Disease Therapeutics Sales Growth Rate by Type (2011-2016)
4 United States Huntington's Disease Therapeutics Sales (Volume) by Application (2011-2016)
4.1 United States Huntington's Disease Therapeutics Sales and Market Share by Application (2011-2016)
4.2 United States Huntington's Disease Therapeutics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Huntington's Disease Therapeutics Manufacturers Profiles/Analysis
5.1 Auspex Pharmaceuticals
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Huntington's Disease Therapeutics Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Auspex Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Alnylam Pharmaceuticals
5.2.2 Huntington's Disease Therapeutics Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Alnylam Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Intellect Neurosciences Incorporation
5.3.2 Huntington's Disease Therapeutics Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Intellect Neurosciences Incorporation Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Lundbeck A/S
5.4.2 Huntington's Disease Therapeutics Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Lundbeck A/S Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Prana Biotechnology Limited
5.5.2 Huntington's Disease Therapeutics Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Prana Biotechnology Limited Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Raptor Pharmaceuticals
5.6.2 Huntington's Disease Therapeutics Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Raptor Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Sangamo Biosciences
5.7.2 Huntington's Disease Therapeutics Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Sangamo Biosciences Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Teva Pharmaceutical Industries
5.8.2 Huntington's Disease Therapeutics Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Trophos SA
5.9.2 Huntington's Disease Therapeutics Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Trophos SA Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Valeant Pharmaceuticals International
5.10.2 Huntington's Disease Therapeutics Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Valeant Pharmaceuticals International Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Vertex Pharmaceuticals
6 Huntington's Disease Therapeutics Manufacturing Cost Analysis
6.1 Huntington's Disease Therapeutics Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Huntington's Disease Therapeutics
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Huntington's Disease Therapeutics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Huntington's Disease Therapeutics Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Huntington's Disease Therapeutics Market Forecast (2016-2021)
10.1 United States Huntington's Disease Therapeutics Sales, Revenue Forecast (2016-2021)
10.2 United States Huntington's Disease Therapeutics Sales Forecast by Type (2016-2021)
10.3 United States Huntington's Disease Therapeutics Sales Forecast by Application (2016-2021)
10.4 Huntington's Disease Therapeutics Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Huntington's Disease Therapeutics
Table Classification of Huntington's Disease Therapeutics
Figure United States Sales Market Share of Huntington's Disease Therapeutics by Type in 2015
Table Application of Huntington's Disease Therapeutics
Figure United States Sales Market Share of Huntington's Disease Therapeutics by Application in 2015
Figure United States Huntington's Disease Therapeutics Sales and Growth Rate (2011-2021)
Figure United States Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
Table United States Huntington's Disease Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Huntington's Disease Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Huntington's Disease Therapeutics Sales Share by Manufacturers
Figure 2016 Huntington's Disease Therapeutics Sales Share by Manufacturers
Table United States Huntington's Disease Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Huntington's Disease Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Huntington's Disease Therapeutics Revenue Share by Manufacturers
Table 2016 United States Huntington's Disease Therapeutics Revenue Share by Manufacturers
Table United States Market Huntington's Disease Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Huntington's Disease Therapeutics Average Price of Key Manufacturers in 2015
Figure Huntington's Disease Therapeutics Market Share of Top 3 Manufacturers
Figure Huntington's Disease Therapeutics Market Share of Top 5 Manufacturers
Table United States Huntington's Disease Therapeutics Sales by Type (2011-2016)
Table United States Huntington's Disease Therapeutics Sales Share by Type (2011-2016)
Figure United States Huntington's Disease Therapeutics Sales Market Share by Type in 2015
Table United States Huntington's Disease Therapeutics Revenue and Market Share by Type (2011-2016)
Table United States Huntington's Disease Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Huntington's Disease Therapeutics by Type (2011-2016)
Table United States Huntington's Disease Therapeutics Price by Type (2011-2016)
Figure United States Huntington's Disease Therapeutics Sales Growth Rate by Type (2011-2016)
Table United States Huntington's Disease Therapeutics Sales by Application (2011-2016)
Table United States Huntington's Disease Therapeutics Sales Market Share by Application (2011-2016)
Figure United States Huntington's Disease Therapeutics Sales Market Share by Application in 2015
Table United States Huntington's Disease Therapeutics Sales Growth Rate by Application (2011-2016)
Figure United States Huntington's Disease Therapeutics Sales Growth Rate by Application (2011-2016)
Table Auspex Pharmaceuticals Basic Information List
Table Auspex Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Auspex Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alnylam Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Intellect Neurosciences Incorporation Basic Information List
Table Intellect Neurosciences Incorporation Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intellect Neurosciences Incorporation Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Lundbeck A/S Basic Information List
Table Lundbeck A/S Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lundbeck A/S Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Prana Biotechnology Limited Basic Information List
Table Prana Biotechnology Limited Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Prana Biotechnology Limited Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Raptor Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Sangamo Biosciences Basic Information List
Table Sangamo Biosciences Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sangamo Biosciences Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Trophos SA Basic Information List
Table Trophos SA Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Trophos SA Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Valeant Pharmaceuticals International Basic Information List
Table Valeant Pharmaceuticals International Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Pharmaceuticals International Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Vertex Pharmaceuticals Basic Information List
Table Vertex Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vertex Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Huntington's Disease Therapeutics
Figure Manufacturing Process Analysis of Huntington's Disease Therapeutics
Figure Huntington's Disease Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Huntington's Disease Therapeutics Major Manufacturers in 2015
Table Major Buyers of Huntington's Disease Therapeutics
Table Distributors/Traders List
Figure United States Huntington's Disease Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure United States Huntington's Disease Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table United States Huntington's Disease Therapeutics Production Forecast by Type (2016-2021)
Table United States Huntington's Disease Therapeutics Consumption Forecast by Application (2016-2021)
  • Global Huntington's Disease Partnering 2012 to 2018
    Published: 01-Apr-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Huntington's Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type ......
  • Huntington's Disease - Epidemiology Forecast to 2027
    Published: 31-Jan-2018        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "Huntington's Disease - Epidemiology Forecast, 2027" report provides a comprehensive analysis of the Huntington's Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2027 Huntington's Disease Epidemiology The epidemiology......
  • Huntington's Disease - Market Insight, Epidemiology and Market Forecast - 2027
    Published: 31-Jan-2018        Price: US 6250 Onwards        Pages: 100
    DelveInsight's "Huntington's Disease - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Huntington's Disease epidemiology and market outlook for the 7MM. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2027 Huntington's Disease Understanding and Treatment Algorithm The market report provides the overvi......
  • Huntington Disease - Pipeline Review, H2 2017
    Published: 21-Dec-2017        Price: US 2000 Onwards        Pages: 287
    Huntington Disease - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Pipeline Review, H2 2017, provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape. Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease that is passed on from parent to child throug......
  • Global Huntington's Disease Partnering 2010 to 2017
    Published: 01-Nov-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Huntington's Disease Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provide......
  • Huntingtin (Huntington Disease Protein or HTT) - Pipeline Review, H2 2017
    Published: 31-Oct-2017        Price: US 3500 Onwards        Pages: 60
    According to the recently published report 'Huntingtin - Pipeline Review, H2 2017'; Huntingtin (Huntington Disease Protein or HTT) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes.Huntingtin (Huntington Disease Protein or HTT) - Huntingtin protein is an encoded by the huntingtin gene, also called the HTT or HD (Huntington disease) gene. Huntingtin up regulates the expression of br......
  • Global Huntington's Disease Therapeutics Market 2017-2021
    Published: 02-Aug-2017        Price: US 3500 Onwards        Pages: 86
    HD is an inherited condition that leads to destruction of nerve cells or neurons. The damage to nerve cells usually causes change in personality, mood swings, irritability and altered behavior. The global HD therapeutics market was witnessing a high unmet demand for disease modifying drug, in the presence of only one approved therapy, Xenazine, and the off-label use of various different therapeutics. The introduction of AUSTEDO in the market will have a significant impact on the market growth......
  • Huntington Disease - Pipeline Review, H1 2017
    Published: 13-Jun-2017        Price: US 2000 Onwards        Pages: 299
    Huntington Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Pipeline Review, H1 2017, provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape. Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease that is passed on from parent to child throug......
  • Huntington Disease - Pipeline Review, H2 2016
    Published: 14-Dec-2016        Price: US 2000 Onwards        Pages: 292
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Pipeline Review, H2 2016, provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape.Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease that is passed on from parent to child through a mutation in their genes. Early symptoms of HD include uncontrolled movements, clumsiness, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs